The U.S. Federal Reserve announced Wednesday that it will keep its benchmark interest rate unchanged at 5.25 to 5.50 per cent. Fed Chairman Jerome Powell has indicated a potential rate cut might come at the next policy meeting in September.

Stockhouse recently sat down with Albert Mason, a prominent financial advisor with Raymond James. Mason has also worked with industry giants such as Merrill Lynch and JP Morgan. His wealth of knowledge and expertise brings a fresh perspective to tailored financial strategies for his client’s portfolios.

Check out the video above to hear Mason break down what the Fed’s hold-steady-for-now approach means. Mason also talks about what analysts forecast for September and what strategies you should consider for your portfolio.

Be sure to stay up to date on all the latest stock market news at Stockhouse.com.

Join the discussion: Find out what everybody’s saying about the Federal Reserve rate cuts and more by checking out Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

More From The Market Online
Canadian flag, medical equipment and stock chart

The top 10 Canadian medical stocks

The Canadian medical industry powers numerous high-potential stocks whose products and services lie at the foundation of human life.
Quantum computer

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal

Cybersecurity stock Quantum eMotion (TSXV:QNC) takes a major step in the go-to-market strategy for its Sentry-Q platform.
An AI generated photo of a stethoscope on a computerized setting

How one company is disrupting PoC testing

When it comes to Gemina Laboratories Ltd. (CSE:GLAB), the Canada and U.K.-based company is progressing a range of PoC diagnostic technologies.
AI generated stock image

Investing in Canadian medical stocks under $10

Healthcare stocks in Canada are publicly traded companies that operate in various sectors of the healthcare industry.